RecruitingPhase 2NCT07589595
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
Sponsor: Eli Lilly and Company
Charlestown, MA · Foxborough, MA · +39 more sites
3 recruiting alzheimer's disease studies with a site in Plymouth, MA.
Sponsor: Eli Lilly and Company
Charlestown, MA · Foxborough, MA · +39 more sites
Sponsor: Lighthouse Pharmaceuticals, Inc.
Boston, MA · Plymouth, MA · Watertown, MA · +36 more sites
Sponsor: Lantheus Biosciences Ltd.
Braintree, MA · Plymouth, MA · +23 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.